Roswell Park Expert to Share Promising Results on New Immunotherapy Approach in Non-Small Cell Lung Cancer
Highlights Investigational drug shows activity in anti-PD1-resistant lung cancer Targeting adenosine may enhance effectiveness of immunotherapy Favorable safety/tolerability profile observed Newswise — BUFFALO, N.Y. and CHICAGO — Patients with advanced …